IMC001 for Clinical Research on Advanced Digestive System Malignancies

ABSTRACT: A Phase I Clinical Study of Autologous T cells modified with chimeric antigen receptor targeting EpCAM ( EPCAM CAR-T) in Patients with malignant tumors of the digestive system (including advanced gastric cancer, colorectal cancer, liver cancer and pancreatic cancer) .

DISEASE(S): Advanced Gastric Cancer,Advanced Hepatocellular Carcinoma,Advanced Pancreatic Cancer,Advanced Colorectal Cancer

PROVIDER: 2388459 | ecrin-mdr-crc |

REPOSITORIES: ECRIN MDR